Schedule 13G ownership disclosure
JAZZ PHARMACEUTICALS PLC
Security class unavailable · CUSIP: G50871105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,700,509
- Percent of class
- 2.7700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-22-000053
- Form type
- SC 13G
- Filer
- Jazz Pharmaceuticals plc
- CIK
- CIK 1232524
- Filed
- Feb 10, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership